Most of the analyzed samples stained positive for AURKA (Table 1), and the increased expression correlated with the decreased overall and progression-free survival very well (Fig. 1b), which is consistent with previous studies in breast [57, 58], gastric [59], ovarian [60], colon [61], and lung [62, 63] cancers. This evidence concerns the gene AURKA and cancer.